GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CureVac NV (MIL:1CVAC) » Definitions » Balance Sheet Cash And Cash Equivalents

CureVac NV (MIL:1CVAC) Balance Sheet Cash And Cash Equivalents


View and export this data going back to 2023. Start your Free Trial

What is CureVac NV Balance Sheet Cash And Cash Equivalents?

Please go to this page to see Cash And Cash Equivalents for non-financial companies.


CureVac NV Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CureVac NV (MIL:1CVAC) » Definitions » Balance Sheet Cash And Cash Equivalents
Traded in Other Exchanges
Address
Friedrich-Miescher-Strasse 15, Tubingen, BW, DEU, 72076
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.